84 related articles for article (PubMed ID: 18788596)
1. [Expression of TGF-beta1 and MMP2 in human renal cell carcinoma and their clinical significance].
Sun RC; Yang SD; Xu ZQ; Guo D; Mu HJ; Fan QH; Hu Q; Zhang LH; Liang JB
Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):184-5. PubMed ID: 18788596
[No Abstract] [Full Text] [Related]
2. The expression and clinical significance of TGF-beta1 and MMP2 in human renal clear cell carcinoma.
Yang SD; Sun RC; Mu HJ; Xu ZQ; Zhou ZY
Int J Surg Pathol; 2010 Apr; 18(2):85-93. PubMed ID: 19223381
[TBL] [Abstract][Full Text] [Related]
3. Expression of Genes Involved in Cellular Adhesion and Extracellular Matrix Remodeling Correlates with Poor Survival of Patients with Renal Cancer.
Boguslawska J; Kedzierska H; Poplawski P; Rybicka B; Tanski Z; Piekielko-Witkowska A
J Urol; 2016 Jun; 195(6):1892-902. PubMed ID: 26631499
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal effects of ascorbate on cancer cell growth and the expression of matrix metalloproteinases and transforming growth factor-beta.
Philips N; Keller T; Holmes C
Cancer Lett; 2007 Oct; 256(1):49-55. PubMed ID: 17602832
[TBL] [Abstract][Full Text] [Related]
5. Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma.
Campagna R; Cecati M; Pozzi V; Fumarola S; Pompei V; Milanese G; Galosi AB; Sartini D; Emanuelli M
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):51-55. PubMed ID: 29974846
[TBL] [Abstract][Full Text] [Related]
6. Cell surface engineering of renal cell carcinoma with glycosylphosphatidylinositol-anchored TIMP-1 blocks TGF- β 1 activation and reduces regulatory ID gene expression.
Notohamiprodjo S; Djafarzadeh R; Rieth N; Hofstetter M; Jaeckel C; Nelson PJ
Biol Chem; 2012 Dec; 393(12):1463-70. PubMed ID: 23667903
[TBL] [Abstract][Full Text] [Related]
7. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
8. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells and TGF-β1 in clinically localized renal cell carcinoma: Comparison with age-matched healthy controls.
Kim CS; Kim Y; Kwon T; Yoon JH; Kim KH; You D; Hong JH; Ahn H; Jeong IG
Urol Oncol; 2015 Mar; 33(3):113.e19-25. PubMed ID: 25499257
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1-induced Fascin1 promotes cell invasion and metastasis of human 786-0 renal carcinoma cells.
Huang W; Cen S; Kang XL; Wang WF; Wang Y; Chen X
Acta Histochem; 2016 Mar; 118(2):144-51. PubMed ID: 26749573
[TBL] [Abstract][Full Text] [Related]
11. [Transfected miR-1908 inhibits renal fibrosis via targeting transforming growth factor beta 1].
Xie F; Li X; Wei C; Gou L; Dang Y; Shan Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1682-5, 1689. PubMed ID: 26648305
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 decreases epithelial sodium channel functionality in renal collecting duct cells via a Smad4-dependent pathway.
Chang CT; Hung CC; Chen YC; Yen TH; Wu MS; Yang CW; Phillips A; Tian YC
Nephrol Dial Transplant; 2008 Apr; 23(4):1126-34. PubMed ID: 18045816
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma.
Lebdai S; Verhoest G; Parikh H; Jacquet SF; Bensalah K; Chautard D; Rioux Leclercq N; Azzouzi AR; Bigot P
Urol Oncol; 2015 Feb; 33(2):69.e11-8. PubMed ID: 25035170
[TBL] [Abstract][Full Text] [Related]
14. Amplification of epidermal growth factor receptor gene in renal cell carcinoma.
El-Hariry I; Powles T; Lau MR; Sternberg CN; Ravaud A; von der Maase H; Zantl N; Harper P; Rolland F; Audhuy B; Barthel F; Machiels JP; Patel P; Kreuser ED; Hawkins RE
Eur J Cancer; 2010 Mar; 46(5):859-62. PubMed ID: 20167476
[TBL] [Abstract][Full Text] [Related]
15. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells.
Rosendahl AH; Forsberg G
Kidney Int; 2006 Nov; 70(9):1584-90. PubMed ID: 16969385
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines.
Shimabukuro T; Ohmoto Y; Naito K
J Urol; 2003 May; 169(5):1865-9. PubMed ID: 12686863
[TBL] [Abstract][Full Text] [Related]
17. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
Ohba K; Miyata Y; Koga S; Kanda S; Kanetake H
Urology; 2005 May; 65(5):1029-34. PubMed ID: 15882758
[TBL] [Abstract][Full Text] [Related]
18. Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells.
Yu L; Wang CY; Shi J; Miao L; Du X; Mayer D; Zhang J
Endocrinology; 2011 Mar; 152(3):773-81. PubMed ID: 21248144
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.
Clark-Greuel JN; Connolly JM; Sorichillo E; Narula NR; Rapoport HS; Mohler ER; Gorman JH; Gorman RC; Levy RJ
Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438
[TBL] [Abstract][Full Text] [Related]
20. Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition.
Boström AK; Möller C; Nilsson E; Elfving P; Axelson H; Johansson ME
Hum Pathol; 2012 May; 43(5):708-19. PubMed ID: 21992819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
